Help guide our efforts to modernize
Send us your comments by March 14, 2020. Menu
Trial record 7 of 35 for:    fop

An Open-Label Extension Study of Palovarotene Treatment in FOP

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02279095
Recruitment Status : Active, not recruiting
First Posted : October 30, 2014
Last Update Posted : January 30, 2019
Information provided by (Responsible Party):
Clementia Pharmaceuticals Inc.